CStone Pharmaceuticals Stock Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5272 EUR | +9.74% |
|
+4.40% | -7.51% |
| Market Cap | 6.77B 995M 872M 804M 753M 1.41B 93.82B 1.44B 9.66B 3.74B 46.37B 3.73B 3.65B 161B | P/E 2026 * |
-318x | P/E 2027 * | 6.32x |
|---|---|---|---|---|---|
| Enterprise Value | 6.24B 917M 804M 741M 694M 1.3B 86.49B 1.33B 8.91B 3.45B 42.75B 3.44B 3.37B 148B | EV / Sales 2026 * |
13x | EV / Sales 2027 * | 1.85x |
| Free-Float |
77.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CStone Pharmaceuticals
| 1 day | +9.74% | ||
| 1 week | +4.40% | ||
| Current month | -37.59% | ||
| 1 month | -37.59% | ||
| 3 months | -45.37% | ||
| 6 months | -9.88% | ||
| Current year | -7.51% |
| 1 week | 0.48 |  | 0.54 |
| 1 month | 0.45 | | 0.62 |
| Current year | 0.45 | | 1.12 |
| 1 year | 0.44 | | 1.35 |
| 3 years | 0.09 | | 1.35 |
| 5 years | 0.09 | | 1.97 |
| 10 years | 0.09 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.74% | +4.40% | - | - | 899M | |
| +0.07% | +3.52% | +20.77% | -10.50% | 64.39B | |
| +1.93% | +6.42% | +57.83% | +229.54% | 56.12B | |
| +7.82% | +44.80% | +44.80% | +44.80% | 40.54B | |
| +0.45% | -0.80% | -50.76% | -58.54% | 37.98B | |
| +0.59% | +8.57% | +72.65% | -23.15% | 31.89B | |
| +1.47% | +15.67% | +148.80% | -43.78% | 26.69B | |
| -0.06% | +9.81% | +67.15% | +84.04% | 22.73B | |
| +6.52% | +5.12% | +3.49% | +174.61% | 16.66B | |
| -0.77% | +4.00% | +60.51% | +123.05% | 16.6B | |
| Average | +2.74% | +6.14% | +47.25% | +57.79% | 34.84B | |
| Weighted average by Cap. | +1.89% | +5.86% | +42.56% | +53.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 479M 70.46M 61.78M 56.95M 53.31M 99.97M 6.65B 102M 684M 265M 3.29B 265M 259M 11.39B | 1.71B 252M 221M 204M 191M 357M 23.76B 365M 2.45B 947M 11.74B 946M 925M 40.72B |
| Net income | -243M -35.75M -31.35M -28.9M -27.05M -50.73M -3.37B -51.78M -347M -134M -1.67B -134M -131M -5.78B | 687M 101M 88.61M 81.68M 76.46M 143M 9.53B 146M 982M 380M 4.71B 379M 371M 16.34B |
| Net Debt | -528M -77.65M -68.08M -62.76M -58.75M -110M -7.32B -112M -754M -292M -3.62B -292M -285M -12.55B | -3.6B -530M -464M -428M -401M -752M -49.97B -767M -5.15B -1.99B -24.69B -1.99B -1.95B -85.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/06/26 | €0.5272 | +9.74% | 0 |
| 26/06/26 | €0.4804 | -2.77% | 0 |
| 25/06/26 | €0.4941 | -5.31% | 0 |
| 24/06/26 | €0.5218 | -2.47% | 0 |
| 23/06/26 | €0.5350 | +5.94% | 6,004 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions
